Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).

Liszewski MK, Leung M, Cui W, Subramanian VB, Parkinson J, Barlow PN, Manchester M, Atkinson JP.

J Biol Chem. 2000 Dec 1;275(48):37692-701.

2.

Conservation in decay accelerating factor (DAF) structure among primates.

Kuttner-Kondo L, Subramanian VB, Atkinson JP, Yu J, Medof ME.

Dev Comp Immunol. 2000 Dec;24(8):815-27.

PMID:
10906393
3.

The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.

Cohen JH, Atkinson JP, Klickstein LB, Oudin S, Subramanian VB, Moulds JM.

Mol Immunol. 1999 Sep-Oct;36(13-14):819-25.

PMID:
10698335
4.

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

Krych-Goldberg M, Hauhart RE, Subramanian VB, Yurcisin BM 2nd, Crimmins DL, Hourcade DE, Atkinson JP.

J Biol Chem. 1999 Oct 29;274(44):31160-8.

5.

Mapping epitopes for 20 monoclonal antibodies to CR1.

Nickells M, Hauhart R, Krych M, Subramanian VB, Geoghegan-Barek K, Marsh HC Jr, Atkinson JP.

Clin Exp Immunol. 1998 Apr;112(1):27-33. Erratum in: Clin Exp Immunol 1998 Aug;113(2):315.

7.

Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.

Mehta JL, Subramanian VB.

Circulation. 1996 Apr 1;93(7):1472; author reply 1473. No abstract available.

PMID:
8641039
8.

Identification of complement receptor type 1-related proteins on primate erythrocytes.

Nickells MW, Subramanian VB, Clemenza L, Atkinson JP.

J Immunol. 1995 Mar 15;154(6):2829-37.

PMID:
7876553
9.

Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms.

Atkinson JP, Krych M, Nickells M, Birmingham D, Subramanian VB, Clemenza L, Alvarez J, Liszewski K.

Clin Exp Immunol. 1994 Aug;97 Suppl 2:1-3. Review. No abstract available.

11.

Comparison of diltiazem at two dose levels with propranolol for treatment of stable angina pectoris.

O'Hara MJ, Khurmi NS, Bowles MJ, Subramanian VB, Doré CJ, Raftery EB.

Am J Cardiol. 1984 Sep 1;54(6):477-81.

PMID:
6383000
12.

Changes of Q wave amplitude during exercise for the prediction of coronary artery disease.

O'Hara MJ, Subramanian VB, Davies AB, Raftery EB.

Int J Cardiol. 1984 Jul;6(1):35-45.

PMID:
6746136
13.

Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris.

Khurmi NS, O'Hara MJ, Bowles MJ, Subramanian VB, Raftery EB.

Am J Cardiol. 1984 Mar 1;53(6):684-8.

PMID:
6367415
14.

Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods.

Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, Raftery EB.

Acta Med Scand Suppl. 1984;681:61-73.

PMID:
6587757
15.

The role of a slow channel inhibitor, verapamil, in the management of hypertension.

Gould BA, Mann S, Kieso H, Subramanian VB, Raftery EB.

Acta Med Scand Suppl. 1984;681:117-23.

PMID:
6587750
16.

Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.

Gould BA, Hornung RS, Mann S, Subramanian VB, Raftery EB.

Hypertension. 1983 Jul-Aug;5(4 Pt 2):II91-6.

PMID:
6862589
17.

Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring.

Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, O'Hara MJ, Raftery EB.

Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):520-1. No abstract available.

18.
19.
20.
21.

Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina.

Subramanian VB, Bowles MJ, Khurmi NS, Davies AB, Raftery EB.

Am J Cardiol. 1982 Oct;50(4):696-703.

PMID:
7124629
22.

Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris.

Packer M, Leon MB, Bonow RO, Kieval J, Rosing DR, Subramanian VB.

Am J Cardiol. 1982 Oct;50(4):903-12. Review. No abstract available.

PMID:
6751066
23.

Additive antianginal effect of verapamil in patients receiving propranolol.

Subramanian VB.

Br Med J (Clin Res Ed). 1982 Jun 19;284(6332):1876. No abstract available.

24.

The 24-hour ambulatory blood pressure profile with verapamil.

Gould BA, Mann S, Kieso H, Subramanian VB, Raftery EB.

Circulation. 1982 Jan;65(1):22-7.

PMID:
7053285
25.

Comparison of antianginal actions of verapamil and propranolol.

Bowles MJ, Subramanian VB, Davies AB, Raftery EB.

Br Med J (Clin Res Ed). 1981 May 30;282(6278):1754. No abstract available.

26.

Pain in the thenar eminence: a rare case of atypical angina.

Lahiri A, Subramanian VB, Craig MW, Raftery EB.

Br Med J. 1980 Sep 20;281(6243):782. No abstract available.

27.

Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise.

Subramanian VB, Lahiri A, Paramasivan R, Raftery EB.

Lancet. 1980 Apr 19;1(8173):841-4.

PMID:
6103208

Supplemental Content

Loading ...
Support Center